Abstract
About this talk
While nanomedicine has been around for several decades, new technological advances are pushing its boundaries. For example, this presentation will present an over 30 year journey of commercializing nanomaterials as implants now in over 45,000 patients to date showing no signs of failure. Current implants face a failure rate of 5 – 10% and sometimes as high as 60% for bone cancer patients. This talk will cover how nanoparticles are being used to diagnose heart problems and develop cardiovascular solutions, including but not limited to stents and cardiac patches. Lastly, this talk will cover how Artificial Intelligence (AI) can be combined into today’s implants to predict implant success or failure in the years that follow.
Speaker
About the speaker
